WO2003095427A1 - Spiro-ring compound - Google Patents

Spiro-ring compound Download PDF

Info

Publication number
WO2003095427A1
WO2003095427A1 PCT/JP2003/005812 JP0305812W WO03095427A1 WO 2003095427 A1 WO2003095427 A1 WO 2003095427A1 JP 0305812 W JP0305812 W JP 0305812W WO 03095427 A1 WO03095427 A1 WO 03095427A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
spiro
ring compound
hydrogen
formulae
Prior art date
Application number
PCT/JP2003/005812
Other languages
French (fr)
Japanese (ja)
Inventor
Shiuji Saito
Hiroki Umemiya
Yoichirou Suga
Masakazu Sato
Naoya Kawashima
Original Assignee
Taisho Pharmaceutical Co.,Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co.,Ltd. filed Critical Taisho Pharmaceutical Co.,Ltd.
Priority to JP2004508514A priority Critical patent/JPWO2003095427A1/en
Priority to AU2003235912A priority patent/AU2003235912A1/en
Publication of WO2003095427A1 publication Critical patent/WO2003095427A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Abstract

A spiro-ring compound represented by the formula (1): (1) wherein the group represented by the formula (2) (2) is any of the formulae (3) to (7): (3) (4) (5) (6) (7) wherein B represents, e.g., a benzene ring optionally substituted by one or more groups of the same or different kinds selected from the group consisting of halogeno, C1-5 alkyls, etc.; R1 and R2 are the same or different and each represents hydrogen, C1-5 alkyl, etc.; R3 represents, e.g., hydrogen, C1-5 alkyl, C1-6 acyl optionally substituted by C1-5 alkoxy, etc.; R4 represents hydrogen or C1-5 alkyl; -X1-X2- represents any of the formulae (8) to (12): -N(R5)-CH2- (8) -O-C(=O)- (9) -O-CH2- (10) -C(=O)-O- (11) -CH2-C(=O)- (12) (wherein R5 represents hydrogen, C3-6 cycloalkyl, etc.); W represents cyclooctyl, C1-3 alkyl substituted by cyclooctyl, or C1-3 alkyl substituted by 1-hydroxycyclooctyl; and m is an integer of 0 to 3. Also provided is a pharmaceutically acceptable salt of the spiro-ring compound.
PCT/JP2003/005812 2002-05-10 2003-05-09 Spiro-ring compound WO2003095427A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2004508514A JPWO2003095427A1 (en) 2002-05-10 2003-05-09 Spiro ring compounds
AU2003235912A AU2003235912A1 (en) 2002-05-10 2003-05-09 Spiro-ring compound

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2002135988 2002-05-10
JP2002-135988 2002-05-10
JP2002-214248 2002-07-23
JP2002214248 2002-07-23

Publications (1)

Publication Number Publication Date
WO2003095427A1 true WO2003095427A1 (en) 2003-11-20

Family

ID=29422399

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2003/005812 WO2003095427A1 (en) 2002-05-10 2003-05-09 Spiro-ring compound

Country Status (3)

Country Link
JP (1) JPWO2003095427A1 (en)
AU (1) AU2003235912A1 (en)
WO (1) WO2003095427A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006058303A3 (en) * 2004-11-29 2006-12-21 Vertex Pharma Modulators of muscarinic receptors
US7879834B2 (en) 2004-08-19 2011-02-01 Vertex Pharmaceuticals Incorporated Spiroindoline modulators of muscarinic receptors
WO2011060035A1 (en) 2009-11-16 2011-05-19 Eli Lilly And Company Spiropiperidine compounds as orl-1 receptor antagonists
WO2011060217A1 (en) 2009-11-16 2011-05-19 Eli Lilly And Company Spiropiperidine compounds as orl-1 receptor antagonists
US8263605B2 (en) 2006-02-22 2012-09-11 Vertex Pharmaceutical Incorporated Modulators of muscarinic receptors
US8304423B2 (en) 2006-02-22 2012-11-06 Vertex Pharmaceutical Incorporated Modulators of muscarinic receptors
US8367691B2 (en) 2004-08-19 2013-02-05 Vertex Pharmaceutical Incorporated Modulators of muscarinic receptors
US8598164B2 (en) 2010-05-06 2013-12-03 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
US8828996B2 (en) 2011-03-14 2014-09-09 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels
US8916565B2 (en) 2011-02-02 2014-12-23 Vertex Pharmaceuticals Incorporated Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
JP2018058874A (en) * 2010-10-18 2018-04-12 セレニス セラピューティクス ホールディング エスアー Compounds, compositions and methods useful for cholesterol mobilization
US10385070B2 (en) 2011-02-18 2019-08-20 Vertex Pharmaceuticals Incorporated Chroman-spirocyclic piperidine amides as modulators of ion channels
JP2022036285A (en) * 2015-12-02 2022-03-04 アストライア セラピューティクス， エルエルシー Piperidinyl nociceptin receptor compounds
US11827617B2 (en) 2015-12-02 2023-11-28 Astraea Therapeutics, Llc Piperidinyl nociceptin receptor compounds

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55143980A (en) * 1979-04-27 1980-11-10 Dai Ichi Seiyaku Co Ltd Anti-allergic preparation
EP0431943A2 (en) * 1989-12-08 1991-06-12 Merck & Co. Inc. Nitrogen-containing spirocycles
WO2000034280A1 (en) * 1998-12-09 2000-06-15 Banyu Pharmaceutical Co., Ltd. 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55143980A (en) * 1979-04-27 1980-11-10 Dai Ichi Seiyaku Co Ltd Anti-allergic preparation
EP0431943A2 (en) * 1989-12-08 1991-06-12 Merck & Co. Inc. Nitrogen-containing spirocycles
WO2000034280A1 (en) * 1998-12-09 2000-06-15 Banyu Pharmaceutical Co., Ltd. 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879834B2 (en) 2004-08-19 2011-02-01 Vertex Pharmaceuticals Incorporated Spiroindoline modulators of muscarinic receptors
US8497295B2 (en) 2004-08-19 2013-07-30 Vertex Pharmaceuticals Incorporated Spiroindoline modulators of muscarinic receptors
US8367691B2 (en) 2004-08-19 2013-02-05 Vertex Pharmaceutical Incorporated Modulators of muscarinic receptors
US8258148B2 (en) 2004-08-19 2012-09-04 Vertex Pharmaceutical Incorporated Spiroindoline modulators of muscarinic receptors
JP2008521825A (en) * 2004-11-29 2008-06-26 バーテックス ファーマシューティカルズ インコーポレイテッド Muscarinic receptor modulators
WO2006058303A3 (en) * 2004-11-29 2006-12-21 Vertex Pharma Modulators of muscarinic receptors
US8304423B2 (en) 2006-02-22 2012-11-06 Vertex Pharmaceutical Incorporated Modulators of muscarinic receptors
US8263605B2 (en) 2006-02-22 2012-09-11 Vertex Pharmaceutical Incorporated Modulators of muscarinic receptors
US8232289B2 (en) 2009-11-16 2012-07-31 Eli Lilly And Company Spiropiperidine compounds as ORL-1 receptor antagonists
WO2011060035A1 (en) 2009-11-16 2011-05-19 Eli Lilly And Company Spiropiperidine compounds as orl-1 receptor antagonists
WO2011060217A1 (en) 2009-11-16 2011-05-19 Eli Lilly And Company Spiropiperidine compounds as orl-1 receptor antagonists
US8598164B2 (en) 2010-05-06 2013-12-03 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
JP2018058874A (en) * 2010-10-18 2018-04-12 セレニス セラピューティクス ホールディング エスアー Compounds, compositions and methods useful for cholesterol mobilization
US10220040B2 (en) 2010-10-18 2019-03-05 Cerenis Therapeutics Holding Sa Compounds, compositions and methods useful for cholesterol mobilization
US8916565B2 (en) 2011-02-02 2014-12-23 Vertex Pharmaceuticals Incorporated Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
US9511067B2 (en) 2011-02-02 2016-12-06 Vertex Pharmaceuticals Incorporated Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channels
US10385070B2 (en) 2011-02-18 2019-08-20 Vertex Pharmaceuticals Incorporated Chroman-spirocyclic piperidine amides as modulators of ion channels
US9181273B2 (en) 2011-03-14 2015-11-10 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels
US8828996B2 (en) 2011-03-14 2014-09-09 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels
JP2022036285A (en) * 2015-12-02 2022-03-04 アストライア セラピューティクス， エルエルシー Piperidinyl nociceptin receptor compounds
US11827617B2 (en) 2015-12-02 2023-11-28 Astraea Therapeutics, Llc Piperidinyl nociceptin receptor compounds
USRE49825E1 (en) 2015-12-02 2024-02-06 Astraea Therapeutics, Llc Piperidinyl nociceptin receptor compounds
JP7472175B2 (en) 2015-12-02 2024-04-22 アストライア セラピューティクス， エルエルシー Piperidinyl Nociceptin Receptor Compounds

Also Published As

Publication number Publication date
JPWO2003095427A1 (en) 2005-09-15
AU2003235912A1 (en) 2003-11-11

Similar Documents

Publication Publication Date Title
WO2003095427A1 (en) Spiro-ring compound
WO2005061458A3 (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
EP1375472A4 (en) Benzene compound and salt thereof
EP1679069A4 (en) Novel piperidine derivative
EP1642880A4 (en) Hsp90 family protein inhibitors
EP1468990A4 (en) Piperazine derivative
WO2004103977A3 (en) Process for the preparation of pyrimidine derivatives
EA200100310A1 (en) OXYGEN CONTAINING HETEROCYCLIC COMPOUNDS
EP1295867A4 (en) Biphenyl compound
WO2005020293A3 (en) Highly conducting and transparent thin films formed from new fluorinated derivatives of 3,4-ethylenedioxythiophene
DE60011269D1 (en) AZAIDOLE WITH SEROTONIN RECEPTOR AFFINITY
WO2003078390A8 (en) Phenolic compound and recording material containing the same
MXPA04002569A (en) Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines.
EP0926146A4 (en) Chromene compounds
EP1468692A3 (en) Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma
WO2002000638A3 (en) Substituted phthalides as anti-convulsive drugs
AU2001269540A1 (en) Serotonin reuptake inhibitors
EP1306369A4 (en) Novel sulfur compounds and intermolecular compounds containing the same as the component compound
EP1535920A4 (en) Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
EP1493765A4 (en) Organic polymers having at the ends epoxy- and/or oxetanyl-containing silicon groups and process for production thereof
EP1310490A4 (en) Gpr14 antagonist
EP1424326A4 (en) Fused-polycyclic compounds
ES2120498T3 (en) NEW TETRACYCLIC COMPOUND.
NO20031046D0 (en) Process for the preparation of a substituted imidazopyridine compound
WO2004099130A3 (en) 1,2-diarylimidazoles useful as inhibitors of cox

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2004508514

Country of ref document: JP

122 Ep: pct application non-entry in european phase